Jaen Juan C.
Insider CIK 1422996 · CCXI SVP, Drug Discovery & CSO · RCUS President, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-07-10 | 2026-07-13 | 19,799 | $28.61 | $566.4K | 822,508 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-07-10 | 2026-07-13 | 268 | $29.40 | $7.9K | 822,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-07-09 | 2026-07-13 | 48,502 | $30.05 | $1.46M | 842,307 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-06-24 | 2026-06-24 | 6,431 | $29.66 | $190.7K | 890,809 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-06-23 | 2026-06-24 | 14,067 | $27.69 | $389.5K | 898,937 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-06-23 | 2026-06-24 | 1,697 | $28.06 | $47.6K | 897,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-06-22 | 2026-06-24 | 9,236 | $27.03 | $249.6K | 913,004 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2026-01-23 | 2026-01-26 | 126,000 | — | $0 | 126,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2026-01-23 | 2026-01-26 | 31,000 | — | $0 | 377,012 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-01-05 | 2026-01-07 | 100 | $23.20 | $2.3K | 922,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-01-05 | 2026-01-07 | 29,670 | $21.34 | $633.2K | 924,393 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2026-01-05 | 2026-01-07 | 2,053 | $22.34 | $45.9K | 922,340 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-12-17 | 2025-12-18 | 9,983 | $22.16 | $221.2K | 346,012 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-12-16 | 2025-12-18 | 11,225 | $21.88 | $245.6K | 355,995 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-12-04 | 2025-12-05 | 82,997 | $24.71 | $2.05M | 954,063 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 5,050 | $19.75 | $99.7K | 1,037,060 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 7,836 | $20.71 | $162.3K | 1,042,110 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 37,114 | $20.23 | $750.8K | 1,049,946 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-10-30 | 2025-11-03 | 4,314 | $20.32 | $87.7K | 1,087,060 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-10-29 | 2025-10-30 | 800 | $22.04 | $17.6K | 1,091,374 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-10-29 | 2025-10-30 | 29,365 | $21.53 | $632.2K | 1,092,174 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-10-29 | 2025-10-30 | 47,675 | $20.49 | $976.9K | 1,121,539 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2025-10-28 | 2025-10-30 | 19,019 | $20.19 | $384.0K | 1,169,214 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2025-01-23 | 2025-01-27 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2025-01-23 | 2025-01-27 | 50,000 | — | $0 | 367,220 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | F Tax w/h | 2024-12-15 | 2024-12-17 | 17,286 | $16.08 | $278.0K | 317,220 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | F Tax w/h | 2024-06-15 | 2024-06-18 | 6,969 | $16.97 | $118.3K | 334,506 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2024-02-27 | 2024-02-28 | 23,132 | $20.10 | $465.0K | 1,188,233 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 3,900 | $20.06 | $78.2K | 1,211,365 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2024-01-23 | 2024-01-25 | 162,400 | — | $0 | 162,400 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2024-01-23 | 2024-01-25 | 40,000 | — | $0 | 341,475 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2024-01-02 | 2024-01-04 | 6,975 | $20.09 | $140.1K | 1,215,265 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | D To issuer | 2023-12-19 | 2023-12-20 | 6,259 | $18.09 | $113.2K | 301,475 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | D To issuer | 2023-12-18 | 2023-12-20 | 6,128 | $17.74 | $108.7K | 307,734 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | D To issuer | 2023-06-16 | 2023-06-16 | 4,820 | $19.35 | $93.3K | 313,862 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | G Gift | 2023-06-15 | 2023-06-16 | 6,000 | — | $0 | 318,682 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2023-01-23 | 2023-01-25 | 185,900 | — | $0 | 185,900 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2023-01-23 | 2023-01-25 | 45,800 | — | $0 | 324,682 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2022-12-16 | 2022-12-16 | 701 | $31.23 | $21.9K | 218,258 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2022-12-16 | 2022-12-16 | 3,735 | $30.66 | $114.5K | 218,959 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2022-06-17 | 2022-06-21 | 1,789 | $22.29 | $39.9K | 210,037 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2022-06-17 | 2022-06-21 | 748 | $21.71 | $16.2K | 211,826 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2022-06-16 | 2022-06-21 | 2,333 | $20.72 | $48.3K | 212,574 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2022-03-08 | 2022-03-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2022-03-08 | 2022-03-10 | 31,250 | — | $0 | 232,407 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | G Gift | 2022-02-28 | 2022-03-02 | 350,000 | — | $0 | 1,222,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 401 | $41.42 | $16.6K | 201,157 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 246 | $38.79 | $9.5K | 202,019 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 157 | $39.67 | $6.2K | 201,862 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-17 | 2021-12-20 | 304 | $40.57 | $12.3K | 201,558 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-16 | 2021-12-20 | 233 | $40.46 | $9.4K | 202,265 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-12-16 | 2021-12-20 | 632 | $39.59 | $25.0K | 202,498 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-06-17 | 2021-06-21 | 2,675 | $23.68 | $63.3K | 198,286 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-06-16 | 2021-06-21 | 2,095 | $24.13 | $50.6K | 201,048 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | S Sale | 2021-06-16 | 2021-06-21 | 87 | $24.77 | $2.2K | 200,961 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2021-01-19 | 2021-01-20 | 116,250 | — | $0 | 116,250 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2021-01-19 | 2021-01-20 | 19,375 | — | $0 | 208,768 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | G Gift | 2020-10-13 | 2020-10-15 | 1,207,000 | — | $0 | 1,572,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2020-06-04 | 2020-06-08 | 55,000 | — | $0 | 244,393 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2020-01-17 | 2020-01-22 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-06-28 | 2019-06-28 | 4,894 | $7.89 | $38.6K | 2,779,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-06-27 | 2019-06-28 | 10,106 | $7.44 | $75.2K | 2,774,346 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-06-03 | 2019-06-04 | 10,000 | $8.25 | $82.5K | 2,764,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2019-01-16 | 2019-01-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2018-11-13 | 2018-11-15 | 10,000 | $11.80 | $118.0K | 2,754,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2018-08-13 | 2018-08-13 | 3,159 | $11.77 | $37.2K | 2,744,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2018-08-10 | 2018-08-13 | 2,579 | $11.94 | $30.8K | 2,741,081 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2018-08-09 | 2018-08-13 | 4,262 | $11.93 | $50.8K | 2,738,502 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 125,012 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 29,936 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 2,020,202 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2018-03-19 | 2018-03-19 | 66,666 | $15.00 | $1000.0K | 2,734,240 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion | 2018-03-19 | 2018-03-19 | 2,175,150 | — | $0 | 2,667,574 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2013-07-23 | 2013-07-26 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-03-08 | 2013-03-11 | 2,095 | $13.98 | $29.3K | 30,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-03-07 | 2013-03-11 | 700 | $13.95 | $9.8K | 32,095 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-03-06 | 2013-03-06 | 4,247 | $13.97 | $59.3K | 32,795 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-03-05 | 2013-03-06 | 2,950 | $13.97 | $41.2K | 37,042 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-03-04 | 2013-03-06 | 5,008 | $13.96 | $69.9K | 39,992 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-28 | 2013-03-01 | 99 | — | $0 | 102,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-28 | 2013-03-01 | 5,000 | — | $0 | 97,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-28 | 2013-03-01 | 99 | $12.56 | $1.2K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-28 | 2013-03-01 | 99 | $4.30 | $426 | 45,099 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-28 | 2013-03-01 | 5,000 | $13.14 | $65.7K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-28 | 2013-03-01 | 5,000 | $4.30 | $21.5K | 50,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-27 | 2013-03-01 | 2,599 | — | $0 | 107,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-27 | 2013-03-01 | 4,901 | — | $0 | 102,599 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-27 | 2013-03-01 | 4,901 | $12.55 | $61.5K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-27 | 2013-03-01 | 4,901 | $4.30 | $21.1K | 49,901 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-27 | 2013-03-01 | 2,599 | $12.56 | $32.6K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-27 | 2013-03-01 | 2,599 | $4.30 | $11.2K | 47,599 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-26 | 2013-02-26 | 5,000 | — | $0 | 112,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-26 | 2013-02-26 | 99 | — | $0 | 117,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-26 | 2013-02-26 | 2,401 | — | $0 | 110,099 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-26 | 2013-02-26 | 2,401 | $4.30 | $10.3K | 47,401 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-26 | 2013-02-26 | 5,000 | $12.35 | $61.8K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-26 | 2013-02-26 | 5,000 | $4.30 | $21.5K | 50,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-26 | 2013-02-26 | 99 | $12.22 | $1.2K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-26 | 2013-02-26 | 99 | $4.30 | $426 | 45,099 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-26 | 2013-02-26 | 2,401 | $12.40 | $29.8K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-25 | 2013-02-26 | 7,401 | — | $0 | 117,599 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-25 | 2013-02-26 | 99 | — | $0 | 125,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-25 | 2013-02-26 | 7,401 | $12.28 | $90.9K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-25 | 2013-02-26 | 7,401 | $4.30 | $31.8K | 52,401 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-25 | 2013-02-26 | 99 | $12.04 | $1.2K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-25 | 2013-02-26 | 99 | $4.30 | $426 | 45,099 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-22 | 2013-02-26 | 7,401 | — | $0 | 125,099 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-22 | 2013-02-26 | 99 | — | $0 | 132,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-22 | 2013-02-26 | 7,401 | $12.05 | $89.2K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-22 | 2013-02-26 | 7,401 | $4.30 | $31.8K | 52,401 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-22 | 2013-02-26 | 99 | $11.89 | $1.2K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-22 | 2013-02-26 | 99 | $4.30 | $426 | 45,099 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-21 | 2013-02-21 | 1,100 | — | $0 | 132,599 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-21 | 2013-02-21 | 1,100 | $11.89 | $13.1K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-21 | 2013-02-21 | 1,100 | $4.30 | $4.7K | 46,100 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-20 | 2013-02-21 | 5,601 | — | $0 | 133,699 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-20 | 2013-02-21 | 5,601 | $11.90 | $66.7K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-20 | 2013-02-21 | 5,601 | $4.30 | $24.1K | 50,601 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-19 | 2013-02-21 | 6,800 | — | $0 | 140,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-19 | 2013-02-21 | 700 | — | $0 | 139,300 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-19 | 2013-02-21 | 8,000 | $11.95 | $95.6K | 45,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-19 | 2013-02-21 | 700 | $11.85 | $8.3K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-19 | 2013-02-21 | 700 | $4.30 | $3.0K | 53,700 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-19 | 2013-02-21 | 6,800 | $11.86 | $80.6K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-19 | 2013-02-21 | 6,800 | $4.30 | $29.2K | 59,800 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-15 | 2013-02-19 | 1,245 | — | $0 | 147,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-15 | 2013-02-19 | 700 | — | $0 | 146,800 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-15 | 2013-02-19 | 1,245 | $4.30 | $5.4K | 54,245 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-15 | 2013-02-19 | 700 | $11.78 | $8.2K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-15 | 2013-02-19 | 700 | $4.30 | $3.0K | 53,700 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-15 | 2013-02-19 | 1,245 | $11.71 | $14.6K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-07 | 2013-02-08 | 1,555 | — | $0 | 148,745 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-07 | 2013-02-08 | 1,555 | $4.30 | $6.7K | 54,555 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-07 | 2013-02-08 | 1,555 | $11.65 | $18.1K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-04 | 2013-02-06 | 775 | — | $0 | 153,400 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-04 | 2013-02-06 | 3,100 | — | $0 | 150,300 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-04 | 2013-02-06 | 775 | $11.67 | $9.0K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-04 | 2013-02-06 | 3,100 | $4.30 | $13.3K | 56,100 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-04 | 2013-02-06 | 3,100 | $11.69 | $36.2K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-04 | 2013-02-06 | 775 | $4.30 | $3.3K | 53,775 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-02-01 | 2013-02-01 | 6,725 | — | $0 | 154,175 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-01 | 2013-02-01 | 1,600 | $4.30 | $6.9K | 54,600 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-02-01 | 2013-02-01 | 5,125 | $4.30 | $22.0K | 58,125 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-01 | 2013-02-01 | 1,600 | $11.65 | $18.6K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-02-01 | 2013-02-01 | 5,125 | $11.60 | $59.5K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-31 | 2013-02-01 | 3,280 | — | $0 | 160,900 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-31 | 2013-02-01 | 1,680 | $4.30 | $7.2K | 54,680 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-31 | 2013-02-01 | 1,680 | $11.45 | $19.2K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-31 | 2013-02-01 | 1,600 | $4.30 | $6.9K | 54,600 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-31 | 2013-02-01 | 1,600 | $11.57 | $18.5K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-29 | 2013-01-29 | 4,892 | — | $0 | 164,180 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-29 | 2013-01-29 | 4,892 | $4.30 | $21.0K | 57,892 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-29 | 2013-01-29 | 4,892 | $11.45 | $56.0K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-28 | 2013-01-29 | 2,710 | — | $0 | 169,072 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-28 | 2013-01-29 | 928 | $11.45 | $10.6K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-28 | 2013-01-29 | 1,782 | $4.30 | $7.7K | 54,782 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-28 | 2013-01-29 | 1,782 | $11.35 | $20.2K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-28 | 2013-01-29 | 928 | $4.30 | $4.0K | 53,928 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-25 | 2013-01-29 | 96 | — | $0 | 171,782 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-25 | 2013-01-29 | 96 | $4.30 | $413 | 53,096 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-25 | 2013-01-29 | 96 | $11.35 | $1.1K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-24 | 2013-01-24 | 1,200 | — | $0 | 171,878 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-24 | 2013-01-24 | 1,200 | $11.35 | $13.6K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-24 | 2013-01-24 | 1,200 | $4.30 | $5.2K | 54,200 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-22 | 2013-01-24 | 100 | — | $0 | 173,078 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-22 | 2013-01-24 | 100 | $11.35 | $1.1K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-22 | 2013-01-24 | 100 | $4.30 | $430 | 53,100 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-12 | 2013-01-15 | 3,305 | — | $0 | 173,178 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-12 | 2013-01-15 | 3,305 | $11.35 | $37.5K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-12 | 2013-01-15 | 3,305 | $4.30 | $14.2K | 56,305 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-04 | 2013-01-04 | 96 | — | $0 | 176,483 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-04 | 2013-01-04 | 96 | $4.30 | $413 | 53,096 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-04 | 2013-01-04 | 96 | $11.35 | $1.1K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-03 | 2013-01-04 | 100 | — | $0 | 176,579 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-03 | 2013-01-04 | 100 | $11.35 | $1.1K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-03 | 2013-01-04 | 100 | $4.30 | $430 | 53,100 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2013-01-02 | 2013-01-04 | 5,821 | — | $0 | 176,679 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-02 | 2013-01-04 | 821 | $11.35 | $9.3K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-02 | 2013-01-04 | 821 | $4.30 | $3.5K | 53,821 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2013-01-02 | 2013-01-04 | 5,000 | $11.25 | $56.3K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2013-01-02 | 2013-01-04 | 5,000 | $4.30 | $21.5K | 58,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2012-12-18 | 2012-12-19 | 7,500 | — | $0 | 182,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-12-18 | 2012-12-19 | 5,000 | $11.15 | $55.8K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-12-18 | 2012-12-19 | 2,500 | $11.05 | $27.6K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2012-12-18 | 2012-12-19 | 2,500 | $4.30 | $10.8K | 55,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2012-12-18 | 2012-12-19 | 5,000 | $4.30 | $21.5K | 58,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise deriv | 2012-12-17 | 2012-12-19 | 7,500 | — | $0 | 190,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2012-12-17 | 2012-12-19 | 5,000 | $4.30 | $21.5K | 58,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-12-17 | 2012-12-19 | 5,000 | $10.95 | $54.8K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | M Exercise | 2012-12-17 | 2012-12-19 | 2,500 | $4.30 | $10.8K | 55,500 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-12-17 | 2012-12-19 | 2,500 | $11.05 | $27.6K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-11-14 | 2012-11-16 | 2,000 | $12.95 | $25.9K | 53,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-11-06 | 2012-11-08 | 5,833 | $12.01 | $70.1K | 55,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-10-01 | 2012-10-01 | 2,100 | $11.98 | $25.2K | 60,833 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-09-27 | 2012-10-01 | 300 | $11.95 | $3.6K | 62,933 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-09-25 | 2012-09-27 | 7,401 | $11.96 | $88.5K | 63,233 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-09-24 | 2012-09-24 | 2,705 | $11.96 | $32.4K | 70,634 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-09-21 | 2012-09-24 | 200 | $12.01 | $2.4K | 73,339 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-09-20 | 2012-09-24 | 661 | $12.01 | $7.9K | 73,539 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2012-09-17 | 2012-09-19 | 800 | $12.05 | $9.6K | 74,200 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2012-07-24 | 2012-07-26 | 110,664 | — | $0 | 110,664 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2012-02-27 | 2012-02-29 | 24,712 | — | $0 | 24,712 | SEC↗ |